The store will not work correctly when cookies are disabled.
1-{3-[4-(tert-butyl)phenyl]-5-[2-(N,N-dimethylamino)ethyl]-(1,2,4-triazol-4-yl)}-3-phenol
ID: ALA377786
PubChem CID: 11717551
Max Phase: Preclinical
Molecular Formula: C22H28N4O
Molecular Weight: 364.49
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)CCc1nnc(-c2ccc(C(C)(C)C)cc2)n1-c1cccc(O)c1
Standard InChI: InChI=1S/C22H28N4O/c1-22(2,3)17-11-9-16(10-12-17)21-24-23-20(13-14-25(4)5)26(21)18-7-6-8-19(27)15-18/h6-12,15,27H,13-14H2,1-5H3
Standard InChI Key: GXCHDJZRSKYWDS-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
-0.6323 -8.1792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0371 -7.6870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2260 -6.9008 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0551 -6.9075 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3053 -7.6974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7546 -8.0831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7695 -8.9090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4912 -9.3073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4572 -7.6571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6287 -9.0009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3421 -9.4176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3370 -10.2418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6193 -10.6504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0948 -10.2287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0862 -9.4059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1793 -8.0517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1973 -8.8774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8134 -10.6339 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9209 -9.2736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3292 -8.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5042 -9.9833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6424 -9.6738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0880 -7.9580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7051 -7.4104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4878 -7.6710 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.1049 -7.1234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6535 -8.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12 13 2 0
6 7 2 0
13 14 1 0
1 2 1 0
14 15 2 0
15 10 1 0
1 10 1 0
7 8 1 0
8 17 2 0
16 17 1 0
3 4 1 0
14 18 1 0
16 9 2 0
17 19 1 0
9 6 1 0
19 20 1 0
2 6 1 0
19 21 1 0
4 5 2 0
19 22 1 0
5 1 1 0
5 23 1 0
10 11 2 0
23 24 1 0
2 3 2 0
24 25 1 0
11 12 1 0
25 26 1 0
25 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 364.49 | Molecular Weight (Monoisotopic): 364.2263 | AlogP: 4.04 | #Rotatable Bonds: 5 |
Polar Surface Area: 54.18 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.03 | CX Basic pKa: 8.47 | CX LogP: 4.14 | CX LogD: 3.18 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.74 | Np Likeness Score: -1.28 |
References
1. Zhang Q, Keenan SM, Peng Y, Nair AC, Yu SJ, Howells RD, Welsh WJ.. (2006) Discovery of novel triazole-based opioid receptor antagonists., 49 (14): [PMID:16821764] [10.1021/jm0601250] |